Special Issue "Recent Clinical Research on Glaucoma"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 23063
Special Issue Editors

2. Associate Professor-Department of Ophthalmology, Optometry, Otolaryngology and Pathology, School of Medicine, University of Murcia, Murcia, Spain
3. Member-Ophthalmic Research Unit “Santiago Grisolía”/FISABIO, and the Research Group on Cellular and Molecular Ophthalmo-Biology of the University of Valencia, Valencia, Spain
4. Member-Spanish Net of Ophthalmic Research “OFTARED” RD16/0008/0022, of the Institute of Health Carlos III, Madrid, Spain
Interests: glaucoma; OCT, OCTA; perimetry; oxidative stress; antioxidant; optic nerve; macula; visual pathway; diabetic retinopathy
2. Department of Surgery, School of Medicine and Odontology, University of Valencia, Valencia, Spain
3. Research Group on Cellular and Molecular Ophthalmo-Biology of the University of Valencia, Valencia, Spain
4. Spanish Net of Ophthalmic Research “OFTARED” RD16/0008/0022, Institute of Health Carlos III, Madrid, Spain
Interests: ophthalmology; eye sciences; vision sciences; glaucoma; retinopathy; molecular biology
Special Issue Information
Dear Colleagues,
In the past few years, knowledge about glaucoma diagnosis and follow up has evolved dramatically through advances in intraocular pressure (IOP) measurement, corneal biomechanics, structural and functional assessment of the ocular surface, anterior chamber, retina, optic nerve and intracranial visual pathways, as well as the advent of artificial intelligence. In addition, the development of new modalities of IOP-lowering and non-IOP-lowering drugs, alternative deliveries, refined laser technologies, and minimally invasive glaucoma surgery (MIGS) techniques with different implants have widened the therapeutic possibilities for treating this disease. Finally, current insights into risk factors and quality of life in relation to glaucomatous impairment are emerging. The purpose of this Special Issue is to present the latest exciting clinical developments that are taking place in the field of glaucoma.
Dr. Jose Javier Garcia-Medina
Dr. Maria Dolores Pinazo-Duran
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glaucoma research
- intraocular pressure
- cornea/ocular surface
- imaging
- perimetry/electrophysiology
- structure/function relationship
- drug
- laser
- surgery
- risk factors/quality of life